RUO Aducanumab是一種選擇性靶向聚集的淀粉樣蛋白β的人單克隆抗體。在阿爾茨海默病轉(zhuǎn)基因小鼠模型中,aducanumab顯示可進(jìn)入大腦,結(jié)合實質(zhì)淀粉樣蛋白β,并以劑量依賴性方式減少可溶性和不溶性淀粉樣蛋白β。 Aducanumab生物仿制藥-研究級該產(chǎn)品同種型對照:ICH2254 緩沖液:ICH3002 濃度:5mg/ml 純度:>95% by SDS-PAGE 內(nèi)毒素:≤ 1.0 EU/mg as determined by the LAL method 制劑:Sterile, preservative-free, solution in PBS. BSA and Azide free.